Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
2nd International Congress on Prediabetes and the Metabolic Syndrome
Managing Prediabetes: Lifestyle Changes and Novel Preventive Interventions
Barcelona, Spain / April 25-28, 2007
Barcelona - Type 2 diabetes (T2DM) is already a major health problem and it is expected to get worse in the coming years. Patients with T2DM have passed through a prediabetic state, defined as impaired fasting glucose or impaired glucose...
7th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO 7)
Improving and Extending Management of Osteoporosis
Porto, Portugal / March 28-31, 2007
Porto - Like most diseases that affect older people, osteoporosis will become increasingly prevalent with future demographic shifts, experts reported here this week. Given that half of all postmenopausal women will experience fractures, the...
19th World Diabetes Congress
Treating Type 2 Diabetes Mellitus Through Incretin Enhancement
Cape Town, South Africa / December 3-7, 2006
INTRODUCTION The global diabetes epidemic is predicted to grow over the next few decades, from 2.8% in 2000 to 4.4% in 2030 (Wild et al. Diabetes Care 2004;27(5):1047-53). The UK Prospective Diabetes Study (UKPDS) found that intensive...
39th Annual Meeting and Scientific Exhibition of the American Society of Nephrology
Managing Bone and Mineral Metabolism Disorders in Chronic Kidney Disease
San Diego, California / November 14-19, 2006
San Diego - Treatment of end-stage renal disease is challenging if physicians are to prevent the accompanying disorders in bone and mineral metabolism. Because adynamic bone disease is associated with increased vascular calcification risk,...
66th Annual Scientific Sessions of the American Diabetes Association
Potential for an Artificial Pancreas: Addressing Continuous Glucose Monitoring
Washington, DC / June 9-13, 2006
Washington, DC - Shortcomings of conventional blood glucose monitoring techniques include lack of access to real-time glucose information, which can result in poor diabetes control. Real-time continuous glucose monitoring is the ability to...
66th Scientific Sessions of the American Diabetes Association
Treating Patients with the Metabolic Syndrome and Type 2 Diabetes: A Step Beyond Statins
Washington, DC / June 9-13, 2006
Washington - In Canada, there are now more than 2 million patients with type 2 diabetes of whom about two-thirds will die of cardiovascular disease. Approximately 25% of Canadians have the metabolic syndrome, which by itself has been...
15th Annual Meeting of the American Association of Clinical Endocrinologists
Estimating the Overall Event Reduction in Type 2 Diabetes Patients with Fibrate Therapy
Chicago, Illinois / April 26-30, 2006
Chicago - According to the Centers for Disease Control and Prevention, nearly 21 million Americans (or 7% of the population) have diabetes and carry a two- to fourfold greater risk of heart disease or stroke compared with the general...
National Kidney Foundation 2006 Spring Clinical Meetings
Management of Bone and Mineral Abnormalities in Chronic Kidney Disease
Chicago, Illinois / April 19-23, 2006
Chicago - Bone and mineral abnormalities present multiple challenges to the entire nephrology team. Depending on the stage of chronic kidney disease, the type of intervention will vary, and what is appropriate for patients in end-stage...
21st Annual Congress of the European Association of Urology
Finding the Key to Dihydrotestosterone Control in Prostate Cancer Prevention
Paris, France / April 5-8, 2006
Paris - Dihydrotestosterone (DHT) plays a central role in both normal and abnormal prostate growth. Manipulation of DHT levels via inhibition of the enzyme 5 alpha-reductase (5AR) has proven to be an effective means of treating benign...